Induct AS (OSL:INDCT)
3.680
0.00 (0.00%)
At close: Apr 16, 2025
Induct AS Revenue
Induct AS had revenue of 4.54M NOK in the quarter ending March 31, 2025, a decrease of -9.55%. This brings the company's revenue in the last twelve months to 17.02M, down -17.46% year-over-year. In the year 2024, Induct AS had annual revenue of 17.50M, down -16.82%.
Revenue (ttm)
17.02M
Revenue Growth
-17.46%
P/S Ratio
4.40
Revenue / Employee
945.72K
Employees
18
Market Cap
74.92M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.50M | -3.54M | -16.82% |
Dec 31, 2023 | 21.04M | 1.60M | 8.25% |
Dec 31, 2022 | 19.44M | 5.13M | 35.85% |
Dec 31, 2021 | 14.31M | 2.70M | 23.32% |
Dec 31, 2020 | 11.60M | -2.18M | -15.84% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 537.23M |
Medistim ASA | 556.16M |
Photocure ASA | 525.39M |
Vistin Pharma ASA | 429.50M |
ArcticZymes Technologies ASA | 108.11M |
Omda AS | 426.27M |
Hofseth BioCare ASA | 265.54M |
Nykode Therapeutics AS | 104.04M |